Deka Bank Deutsche Girozentrale Cytom X Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$6.33 - $9.91 $63,933 - $100,091	-10,100 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$6.55 - $8.83 $66,155 - $89,183	10,100 New	10,100 $66,000
Q3 2019 Nov 14, 2019	SELL	$7.38 - $12.25 $178,596 - $296,450	-24,200 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$9.35 - $11.41 $88,825 - $108,395	9,500 Added 64.63%	24,200 $257,000
Q1 2019 May 10, 2019	BUY	$9.5 - $19.16 $24,700 - $49,816	2,600 Added 21.49%	14,700 $334,000
Q4 2018 Feb 12, 2019	SELL	$12.69 - $18.61 $32,994 - $48,386	-2,600 Reduced 17.69%	12,100 $178,000
Q3 2018 Nov 09, 2018	SELL	$18.04 - $26.41 $7,216 - $10,564	-400 Reduced 2.65%	14,700 $0
Q2 2018 Aug 14, 2018	SELL	$21.38 - $29.68 $256,560 - $356,160	-12,000 Reduced 44.28%	15,100 $345,000
Q1 2018 May 03, 2018	BUY	$21.76 - $34.22 $589,696 - $927,362	27,100 New	27,100 $761,000

50.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $58.7M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.